Contact

Jamie Lacey-Moreira, PressComm PR Principal & Founder

Are you ready to give your communications strategy a new perspective? The PressComm PR team works with life science and health care organizations, delivering a flexible, resource-leveraging communications program.

Please contact Jamie to let us know how we can help your organization:

Jamie Lacey-Moreira, Principal
PressComm PR, LLC
Ph: 410.299.3310
Email: jamielacey@presscommpr.com

News

May 8, 2019

MaxCyte Progresses Phase I Clinical Trial of Lead mRNA-based Cell Therapy from its CARMA™ Platform
– No dose-limiting toxicities or safety concerns observed in first cohort of treated patients– Feasibility of streamlined, faster CAR therapy manufacturing [Read More]
May 6, 2019

UMB startup CoapTech receives FDA clearance for feeding tube placement device
The company's device uses ultrasound, which will allow a feeding tube to be placed without need for a surgical setting. With regulatory approval, it's taking [Read More]
May 1, 2019

MaxCyte Presents at 22nd Annual ASGCT Meeting on Manufacturing Process for First CARMA™ Drug Candidate, Including One-Day Cell Processing
– CARMA drug candidates can be manufactured via streamlined, single-day process, providing a much needed faster turnaround of autologous cell therapy to patients– CARMA cell [Read More]

PressComm

Contact

Contact

Site Links

Social

About PressComm PR